about
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort.Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.More Than a Decade Follow-up in Severe or Difficult-to-Treat Asthma: TENOR II.Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease.Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients.Recent asthma exacerbations: a key predictor of future exacerbations.Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma.Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma.Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.The response to combination therapy treatment regimens in severe/difficult-to-treat asthma.Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR.Insurance status and asthma-related health care utilization in patients with severe asthma.TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma.
P50
Q30417919-2204D926-1C80-4BE2-BFC5-0B3D02850A39Q30424114-BD8C89C0-CD20-4D99-A5B7-FA90C474BE2DQ30438225-95791982-E883-40CF-884F-5592841058F1Q38629999-5FE30C22-B7DC-485E-80A4-BA42AC9B2D2BQ39658442-63DF0623-9639-4662-AFAE-166B79BF9536Q40204796-1140177F-19E8-4933-B2F6-37BDC3AB6438Q40212173-706CC16E-6043-424D-83CD-AFE54F1283F0Q40297074-AF82E41F-B27E-49FA-B239-630DBF2CCDC7Q44345938-524884A1-4EDB-4039-AEB4-1A9D2D3AAA77Q45932106-F2CF1A49-39AB-47F0-BD57-FD7D8DDF3B92Q46069151-0BC06457-F834-4D09-941E-1C5F6B00AC97Q46442315-E54A81CC-8FEC-4012-B4CB-75B5915C990CQ46761506-286E50C1-6B97-4F51-853F-EEFD2AD59869Q46813515-CAFB28CE-19F6-4B4D-9918-08AD086083D2Q51793737-7725863E-0B25-43AE-89CC-F367818C706CQ53205422-2A0ABAB0-DA6E-407A-8819-C88CBCA7CD65
P50
name
TENOR Study Group
@en
type
label
TENOR Study Group
@en
prefLabel
TENOR Study Group
@en